Adma Biologics | ADMA - Loan Capital

Stock Price
15.02
Daily Change
0.15 1.01%
Monthly
-6.71%
Yearly
-23.56%
Q1 Forecast
14.69

Adma Biologics reported $69.33M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Adma Biologics USD 69.33M 750K Dec/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
BioCryst Pharmaceuticals USD 428.67M 234.31M Dec/2025
Minerva Neurosciences USD 0 86.58M Sep/2024
Novavax USD 246.3M 200K Dec/2025
Omeros USD 403.72M 27.2M Jun/2024
Takeda JPY 4.27T 81.29B Dec/2025